PortfoliosLab logoPortfoliosLab logo
IPO Date
Jan 3, 2023

Highlights

Total Revenue (TTM)
$7.83M
Gross Profit (TTM)
-$639.50K
EBITDA (TTM)
-$5.21M
Year Range
$0.00 - $0.16
ROA (TTM)
-8.01%
ROE (TTM)
-89.85%

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

MLECW Performance Chart

Moolec Science SA Warrant (MLECW) is up 220.7% since the beginning of the year. At $0 per share, MLECW is trading 88.4% below its 52-week high of $0.


Loading charts...

S&P 500 Index

Returns By Period

Moolec Science SA Warrant (MLECW) has returned 220.69% so far this year and 30.07% over the past 12 months.


Moolec Science SA Warrant

1D
5.08%
1M
-7.00%
YTD
220.69%
6M
116.28%
1Y
30.07%
3Y*
-37.14%
5Y*
10Y*

Benchmark (S&P 500 Index)

1D
-1.44%
1M
-1.45%
YTD
7.60%
6M
6.59%
1Y
22.24%
3Y*
19.20%
5Y*
11.54%
10Y*
13.71%
*Multi-year figures are annualized to reflect compound growth (CAGR)

MLECW Monthly Returns History

Based on dividend-adjusted daily data since Jan 3, 2023, MLECW's average daily return is +1.12%, while the average monthly return is +10.05%. At this rate, an investment would double in approximately 0.6 years.

Historically, 45% of months were positive and 55% were negative. The best month was Feb 2026 with a return of +558.6%, while the worst month was Jan 2023 at -90.8%. The longest winning streak lasted 2 consecutive months, and the longest losing streak was 4 months.

On a daily basis, MLECW closed higher 27% of trading days. The best single day was Dec 26, 2024 with a return of +228.0%, while the worst single day was Jan 3, 2023 at -87.1%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202650.00%558.62%-54.97%-1.94%-24.90%-2.11%220.69%
202523.23%25.24%-78.32%98.82%-26.63%31.45%14.72%-43.85%2.86%18.52%-10.16%-49.57%-77.17%
202481.36%43.86%-51.05%87.54%13.85%-16.67%30.00%-46.00%13.96%-0.25%10.03%-42.14%15.45%
2023-90.80%33.42%-43.90%-18.98%-14.41%2.70%-13.39%-6.79%-45.58%-28.49%19.52%-26.67%-98.65%

Benchmark Metrics

Moolec Science SA Warrant has an annualized alpha of 1242.08%, beta of 1.07, and R2 of 0.00 versus S&P 500 Index. Calculated based on daily prices since January 03, 2023.

  • This stock participated in 197.05% of S&P 500 Index downside but only -144.53% of its upside - more exposed to losses than it benefited from rallies.
  • R2 of 0.00 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
1,242.08%
Beta
1.07
0.00
Upside Capture
-144.53%
Downside Capture
197.05%

Return for Risk

Risk / Return Rank

MLECW ranks 64 for risk / return — better than 64% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.


MLECW Risk / Return Rank: 6464
Overall Rank
MLECW Sharpe Ratio Rank: 4747
Sharpe Ratio Rank
MLECW Sortino Ratio Rank: 8686
Sortino Ratio Rank
MLECW Omega Ratio Rank: 8585
Omega Ratio Rank
MLECW Calmar Ratio Rank: 5252
Calmar Ratio Rank
MLECW Martin Ratio Rank: 5050
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Moolec Science SA Warrant (MLECW) and compare them to S&P 500 Index.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


MLECWBenchmarkDifference
Sharpe ratioReturn per unit of total volatility

-1.68

Sortino ratioReturn per unit of downside risk

+0.24

Omega ratioGain probability vs. loss probability

1.34

1.32

+0.02

Calmar ratioReturn relative to maximum drawdown

0.40

2.46

-2.06

Martin ratioReturn relative to average drawdown

0.63

10.92

-10.28

Dividends

Dividend History


Moolec Science SA Warrant doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the Moolec Science SA Warrant. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Moolec Science SA Warrant was 99.71%, occurring on Jan 9, 2026. The portfolio has not yet recovered.

The current Moolec Science SA Warrant drawdown is 98.86%.


Related event

Drawdown

Fall

Recovery

Underwater

2026 bear market2026
-99.71%Jan 2026
3y 7d
3y 5moJan 2023 - now

Drawdown Indicators


MLECWBenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-99.71%

-56.78%

-42.93%

Max Drawdown (1Y)

Largest decline over 1 year

-75.63%

-9.10%

-66.53%

Max Drawdown (3Y)

Largest decline over 3 years

-94.66%

-18.90%

-75.76%

Max Drawdown (5Y)

Largest decline over 5 years

-25.43%

Max Drawdown (10Y)

Largest decline over 10 years

-33.92%

Current Drawdown

Current decline from peak

-98.86%

-3.21%

-95.65%

Average Drawdown

Average peak-to-trough decline

-97.26%

-10.71%

-86.55%

Ulcer Index

Depth and duration of drawdowns from previous peaks

47.50%

2.04%

+45.46%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Moolec Science SA Warrant over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Moolec Science SA Warrant is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
Portfolio Analyzer

Build a portfolio with MLECW

Add Moolec Science SA Warrant to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with MLECW